Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN 47907, USA.
J Control Release. 2011 May 30;152(1):13-20. doi: 10.1016/j.jconrel.2011.02.014. Epub 2011 Feb 23.
Polymer micelles have been used widely for delivery of poorly water-soluble drugs. Such drug delivery, however, has been based primarily on hydrophobic interactions. For better drug loading and improved stability, hydrotropic polymer micelles were used. To develop a versatile polymer micelle for solubilizing various poorly soluble drugs, two different hydrotropic agents were examined. The solubilizing properties of two hydrotropic agents, N,N-diethylnicotinamide (DENA) and N,N-dimethylbenzamide (DMBA), in polymeric form were investigated for their ability to solubilize five drugs with low aqueous solubility covering a wide range of hydrophobicity and molecular structures. The hydrotropes were covalently linked to the hydrophobic block of a block copolymer that also had a hydrophilic poly(ethylene glycol) (PEG) block. The solubilizing capacity of the polymeric hydrotropes was compared with that of the non polymeric hydrotropes, as well as of two conventional (non hydrotropic) copolymer systems. The solubilizing capacity of polymeric hydrotropes reflects combined effects of the micellar solubilization by the hydrophobic micelle core and hydrotropic solubilization. Because of the highly localized configuration, hydrotropes in the polymeric form are more powerful solubilizers than in the monomeric (non-polymeric) solution. It is possible to produce 1~3 orders of magnitude increase in solubility with polymeric hydrotropes at the 1% (w/v) level. Of the two hydrotropic polymeric systems in this study, the DENA-based system is highly specific, whereas the DMBA-based system is a general solubilizer of hydrophobic drugs. An additional advantage of polymeric hydrotropes over the non-polymeric form is absence of high concentrations of free hydrotropes in the formulation. Solubilization vehicles based on polymeric hydrotropes are expected to provide a new and versatile means of preparing formulations for various poorly soluble drugs and drug candidates without using organic solvents. This advantage is accompanied with the inherent controlled release property of the hydrotropic polymer micelles, making them ideal for pharmaceutical formulations used in drug candidate screening and toxicology studies.
聚合物胶束已被广泛用于递运难溶性药物。然而,这种药物递运主要基于疏水相互作用。为了更好地载药和提高稳定性,使用了增溶聚合物胶束。为了开发一种用于溶解各种难溶性药物的多功能聚合物胶束,研究了两种不同的增溶剂。研究了两种增溶剂 N,N-二乙基烟酰胺(DENA)和 N,N-二甲基苯甲酰胺(DMBA)在聚合物形式下的增溶性能,以考察其溶解 5 种具有广泛疏水性和分子结构的低水溶性药物的能力。将增溶剂共价连接到具有亲水性聚(乙二醇)(PEG)嵌段的疏水嵌段共聚物的疏水嵌段上。将聚合物增溶剂的增溶能力与非聚合物增溶剂以及两种常规(非增溶)共聚物系统进行了比较。聚合物增溶剂的增溶能力反映了疏水胶束核的胶束增溶和增溶的综合效应。由于高度局部化的构型,聚合物形式的增溶剂比单体(非聚合物)溶液中的增溶剂更具溶解能力。在 1%(w/v)水平下,使用聚合物增溶剂可以使溶解度提高 1~3 个数量级。在本研究中的两种增溶聚合物系统中,基于 DENA 的系统具有高度特异性,而基于 DMBA 的系统是疏水药物的通用增溶剂。与非聚合物形式相比,聚合物增溶剂的另一个优点是制剂中不存在高浓度的游离增溶剂。基于聚合物增溶剂的增溶剂有望为各种难溶性药物和药物候选物提供一种新的、通用的制剂制备方法,而无需使用有机溶剂。这种优势伴随着增溶聚合物胶束固有的控制释放特性,使它们成为药物候选物筛选和毒理学研究中药物制剂的理想选择。
J Control Release. 2011-2-23
J Control Release. 2005-1-3
J Control Release. 2008-3-3
J Control Release. 2004-6-18
J Pharm Sci. 2010-9
Eur J Pharm Biopharm. 2006-11
RSC Adv. 2019-5-13
Polymers (Basel). 2019-4-2
Biomacromolecules. 2014-11-10
Biomaterials. 2014-8